The Effects of a Ficus Carica on Improvement in Bowl Movements in Female Volunteer With Functional Constipation
Randomized, Double-Blind, Placebo-Controlled, Parallel Trial in Female Volunteers With Functional Constipation, to Evaluate the Improvement in Bowl Movement of Ficus Carica
1 other identifier
interventional
40
1 country
1
Brief Summary
This trial is being conducted to look for following changes when fig paste is taken by female subjects with functional constipation: To evaluate the improvement of the bowel To assess the quality of life and impact on female reproductive function To evaluate the influence on glucose, cholesterol, HDL-cholesterol, LDL-cholesterol
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 16, 2010
CompletedFirst Posted
Study publicly available on registry
August 20, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedFebruary 7, 2012
February 1, 2012
7 months
August 16, 2010
February 6, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Colonic transit time
Colonic transit time is measured in study visit 1 (as screening test), 3 (60day) and 5 (116day).
116 day
Secondary Outcomes (3)
Questionnaire for evacuation
116 day
Questionnaire for quality of life
116 day
Questionnaire for woman reproductive function
116 day
Study Arms (2)
Ficus carica (Fig paste)
EXPERIMENTALControl (Placebo paste)
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Subjects who are female volunteers (unmarried), 19\~40 years
- Subject who have functional constipation by ROME IIII criteria
- Subject who have over 36 hour colonic transit time
- Subject must provide written informed consent to participate in the study
You may not qualify if:
- Subject with a history or evidence of clinically significant gastrointestinal, anorectal, hepatic, renal, neurological, pulmonary, endocrine, blood tumor, psychiatric, Cardiovascular disease
- Subjects who have a gastrointestinal (GI) disease (Crohn's disease, etc.) that would increase the influence with absorbance medication or a GI surgery excluding appendectomy and hernia surgery
- Subject with uterine fibroids at ultrasonography
- Subject is pregnant, planning to become pregnant, or breast-feeding
- Subjects with childbearing potential (i.e. pre-menopausal, not surgically sterile) not willing to use a medically accepted contraceptive (oral contraception) regimen
- Known history of moderate to severe hepatic impairment (i.e., serum ALT\>1.5×ULN, AST\>1.5×ULN)
- Subjects with uncontrolled hypotension (indicated by a sitting systolic blood pressure ≤ 95 mmHg or diastolic blood pressure ≤ 60 mmHg measured) and hypertension (indicated by a sitting systolic blood pressure≥ 150 mmHg or diastolic blood pressure≥ 95 mmHg measured) at vital sign measurement
- Subjects with significant hypersensitivity about Ficus carica
- Subjects who received certain medications that cause the alteration of bowel movement within the past 2weeks prior to first administration
- Subjects who participated in other clinical investigation within 2 months prior to first administration
- Subject who drink constantly (21 units/week over)
- Subject who have Irritable bowel syndrome by ROME IIII criteria
- Any significant condition that, in the opinion of the investigator, could interfere with the subject's participation or compliance in the study (i.e., laboratory test and others)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chonbuk National University Hospital
Jeonju, Jeollabuk-do, 561-712, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Soo-Wan Chae, MD
Chonbuk National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 16, 2010
First Posted
August 20, 2010
Study Start
July 1, 2010
Primary Completion
February 1, 2011
Study Completion
August 1, 2011
Last Updated
February 7, 2012
Record last verified: 2012-02